Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zosurabalpin intravenous safety, tolerability, and pharmacokinetics study in healthy participants
NL-OMON60740Phase 1Completed
- Sponsor
- Roche
- Start
- Sep 2023
- Modality
- Cyclic Peptides → Modified Peptides → Peptides
- Countries
- 1
01
Overview
Phase 1 trial of zosurabalpin, sponsored by Roche. Started Sep 2023; status: completed.
02
Drugs
zosurabalpin
Beyond the preview
Go deeper on NL-OMON60740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60740.